We are live on ! Find out more
MC

Maverick Capital Portfolio holdings

AUM $8.67B
1-Year Est. Return 48.76%
This Fund
S&P 500
This Quarter Est. Return
+8.76%
1 Year Est. Return
+48.76%
3 Year Est. Return
+198.74%
5 Year Est. Return
+110.99%
10 Year Est. Return
+397.6%
AUM
$5.38B
AUM Growth
+$625M
Cap. Flow
+$296M
Cap. Flow %
5.5%
Top 10 Hldgs %
45.46%
Holding
751
New
188
Increased
138
Reduced
234
Closed
190

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$174M
2
GLW icon
Corning
GLW
+$124M
3
TGTX icon
TG Therapeutics
TGTX
+$98.1M
4
BX icon
Blackstone
BX
+$87.5M
5
LOGI icon
Logitech
LOGI
+$85.2M

Sector Composition

Rank Sector Weight
1 Technology 23.93%
2 Healthcare 19.44%
3 Consumer Discretionary 18.07%
4 Communication Services 14.07%
5 Financials 7.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACHC icon
301
Acadia Healthcare
ACHC
$2.95B
$964K 0.02%
32,692
-84,274
-72% -$2.45M
BAC icon
302
Bank of America
BAC
$440B
$962K 0.02%
+39,915
New +$994K
BCC icon
303
Boise Cascade
BCC
$3.04B
$954K 0.02%
23,895
+1,431
+6% +$62.1K
MUSA icon
304
Murphy USA
MUSA
$10.9B
$951K 0.02%
7,414
-1,840
-20% -$243K
OPLN
305
Openlane
OPLN
$4.25B
$946K 0.02%
+65,668
New +$1.03M
AA icon
306
Alcoa
AA
$12.4B
$935K 0.02%
80,396
+50,787
+172% +$682K
LZB icon
307
La-Z-Boy
LZB
$1.67B
$929K 0.02%
29,375
+21,284
+263% +$647K
CVLT icon
308
Commault Systems
CVLT
$5.48B
$922K 0.02%
22,604
+548
+2% +$22.5K
EVTC icon
309
Evertec
EVTC
$2.01B
$918K 0.02%
+26,441
New +$850K
ENDP
310
DELISTED
Endo International plc
ENDP
$908K 0.02%
275,225
+25,016
+10% +$80.2K
CAG icon
311
Conagra Brands
CAG
$7.18B
$900K 0.02%
+25,210
New +$923K
SXT icon
312
Sensient Technologies
SXT
$5.41B
$893K 0.02%
15,461
-8,381
-35% -$462K
HOLX
313
DELISTED
Hologic
HOLX
$888K 0.02%
13,355
+4,114
+45% +$260K
L icon
314
Loews
L
$23.7B
$888K 0.02%
25,562
+2,558
+11% +$91.8K
BRK.B icon
315
Berkshire Hathaway Class B
BRK.B
$1.11T
$877K 0.02%
+4,120
New +$843K
NATI
316
DELISTED
National Instruments Corp
NATI
$869K 0.02%
24,342
-5,866
-19% -$213K
AER icon
317
AerCap
AER
$24.4B
$865K 0.02%
34,324
-2,758
-7% -$79.9K
HUBS icon
318
HubSpot
HUBS
$12.7B
$862K 0.02%
2,950
+1,838
+165% +$482K
CORT icon
319
Corcept Therapeutics
CORT
$11.9B
$857K 0.02%
49,246
-5,618
-10% -$89.5K
HBAN icon
320
Huntington Bancshares
HBAN
$35.5B
$853K 0.02%
93,017
+7,568
+9% +$70.5K
NOW icon
321
ServiceNow
NOW
$122B
$852K 0.02%
+8,780
New +$784K
XEC
322
DELISTED
CIMAREX ENERGY CO
XEC
$852K 0.02%
+34,999
New +$922K
EMN icon
323
Eastman Chemical
EMN
$8.45B
$843K 0.02%
10,795
-38,693
-78% -$2.92M
CXO
324
DELISTED
CONCHO RESOURCES INC.
CXO
$836K 0.02%
18,937
-5
-0% -$249
PKG icon
325
Packaging Corp of America
PKG
$22.8B
$829K 0.02%
7,602
-382
-5% -$39K

Similar funds

Maverick Capital's Q3 2020 Portfolio in Review

As of Q3 2020, Maverick Capital held 751 positions worth $5.38B, up 13% from $4.75B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Maverick Capital deployed $296M of net new capital in Q3 2020, opening 188 new positions and adding to 138 existing holdings. Its largest new stake was Blackstone: 1,634,535 shares worth $85.3M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $86.7M trimmed.

  • Maverick Capital's largest Q3 2020 buy was Blackstone: 1,634,535 shares worth $85.3M.
  • Maverick Capital added most to Lam Research in Q3 2020, an estimated $174M increase.
  • Maverick Capital's biggest Q3 2020 reduction was Meta Platforms (Facebook), cutting an estimated $86.7M.
  • Maverick Capital fully exited Momenta Pharmaceuticals, Inc. in Q3 2020, selling an estimated $77M.
  • Maverick Capital's ten largest holdings make up 45% of its $5.38B portfolio in Q3 2020.
  • Maverick Capital opened 188 new positions and closed 190 in Q3 2020.
  • Maverick Capital's portfolio value rose 13% quarter-over-quarter to $5.38B.

Based on Maverick Capital's 13F filing for Q3 2020, filed 16 Nov 2020.